Anteris Technologies Global (NASDAQ:AVR) Trading Down 4.5% – Here’s What Happened

Anteris Technologies Global Corp. (NASDAQ:AVR) was down 4.5% during trading on Friday . The company traded as low as $5.82 and last traded at $5.97. Approximately 1,259,083 shares changed hands during trading, a decline of 31% from the average daily volume of 1,817,860 shares. The stock had previously closed at $6.25.

Analysts Set New Price Targets

AVR has been the subject of a number of recent analyst reports. Lake Street Capital reiterated a “buy” rating and issued a $15.00 price target on shares of Anteris Technologies Global in a research report on Friday, January 23rd. Weiss Ratings restated a “sell (e+)” rating on shares of Anteris Technologies Global in a research note on Monday, December 29th. One investment analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $15.00.

Anteris Technologies Global Trading Down 4.5%

The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.80 and a current ratio of 0.84. The company has a market capitalization of $245.96 million and a PE ratio of -3.30. The stock has a fifty day moving average of $5.05 and a 200 day moving average of $4.48.

Anteris Technologies Global (NASDAQ:AVR) last announced its quarterly earnings data on Wednesday, November 12th. The company reported ($0.62) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.57) by ($0.05). Anteris Technologies Global had a negative net margin of 3,944.93% and a negative return on equity of 252.71%. The company had revenue of $0.43 million for the quarter, compared to analysts’ expectations of $0.74 million. As a group, sell-side analysts predict that Anteris Technologies Global Corp. will post -2.66 earnings per share for the current fiscal year.

Institutional Trading of Anteris Technologies Global

Several hedge funds have recently bought and sold shares of the stock. L1 Capital Pty Ltd boosted its holdings in shares of Anteris Technologies Global by 143.2% during the 3rd quarter. L1 Capital Pty Ltd now owns 6,838,136 shares of the company’s stock valued at $30,772,000 after purchasing an additional 4,026,136 shares during the last quarter. Nantahala Capital Management LLC lifted its position in shares of Anteris Technologies Global by 13.3% in the third quarter. Nantahala Capital Management LLC now owns 1,918,666 shares of the company’s stock worth $8,634,000 after buying an additional 225,000 shares in the last quarter. JPMorgan Chase & Co. lifted its position in shares of Anteris Technologies Global by 32.7% in the third quarter. JPMorgan Chase & Co. now owns 1,417,627 shares of the company’s stock worth $6,379,000 after buying an additional 349,299 shares in the last quarter. Vanguard Group Inc. boosted its stake in Anteris Technologies Global by 85.1% during the third quarter. Vanguard Group Inc. now owns 745,560 shares of the company’s stock valued at $3,355,000 after buying an additional 342,711 shares during the last quarter. Finally, UBS Group AG boosted its stake in Anteris Technologies Global by 133.3% during the fourth quarter. UBS Group AG now owns 515,725 shares of the company’s stock valued at $2,573,000 after buying an additional 294,695 shares during the last quarter.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.